Spotlight on Galantamine in Alzheimer's Disease This Spotlight is derived from abstract and summary text of an Adis Drug Evaluation originally published in full in PharmacoEconomics 2002; 20 (13): 919-942
Year of publication: |
2003
|
---|---|
Authors: | Lyseng-Williamson, Katherine A. ; Plosker, Greg L. |
Published in: |
Disease Management and Health Outcomes. - Springer Healthcare | Adis, ISSN 1173-8790. - Vol. 11.2003, 2, p. 125-128
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Acetylcholinesterase inhibitors | Adis Spotlights | Alzheimer's disease | Cost analysis | Galantamine | Pharmacoeconomics |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Galantamine: A Pharmacoeconomic Review of its Use in Alzheimer's Disease
Lyseng-Williamson, Katherine A., (2002)
-
Assessment of Health Economics in Alzheimer's Disease (AHEAD): Treatment with Galantamine in Sweden
Garfield, Frances B., (2002)
-
Management of Alzheimer's Disease: Defining the Role of Donepezil
Ibbotson, Tim, (2002)
- More ...
-
Lyseng-Williamson, Katherine A., (2002)
-
Lyseng-Williamson, Katherine A., (2006)
-
Etanercept: A Pharmacoeconomic Review of its Use in Rheumatoid Arthritis
Lyseng-Williamson, Katherine A., (2004)
- More ...